IES20120556A2 - Compositions comprising cetilistat - Google Patents

Compositions comprising cetilistat

Info

Publication number
IES20120556A2
IES20120556A2 IES20120556A IES20120556A IES20120556A2 IE S20120556 A2 IES20120556 A2 IE S20120556A2 IE S20120556 A IES20120556 A IE S20120556A IE S20120556 A IES20120556 A IE S20120556A IE S20120556 A2 IES20120556 A2 IE S20120556A2
Authority
IE
Ireland
Prior art keywords
composition
cetilistat
capsule
formulation
sodium
Prior art date
Application number
IES20120556A
Other languages
English (en)
Inventor
John Robert Bloor
Christopher Robert Dunk
Richard Michael John Palmer
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1122213.0A external-priority patent/GB201122213D0/en
Priority claimed from GBGB1203082.1A external-priority patent/GB201203082D0/en
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of IES20120556A2 publication Critical patent/IES20120556A2/en
Publication of IES86183B2 publication Critical patent/IES86183B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782—Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Logic Circuits (AREA)
  • Manipulation Of Pulses (AREA)
IES20120556A 2011-12-23 2012-12-20 Compositions comprising cetilistat IES86183B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1122213.0A GB201122213D0 (en) 2011-12-23 2011-12-23 Compositions
GBGB1203082.1A GB201203082D0 (en) 2012-02-22 2012-02-22 Compositions

Publications (2)

Publication Number Publication Date
IES20120556A2 true IES20120556A2 (en) 2013-05-08
IES86183B2 IES86183B2 (en) 2013-05-08

Family

ID=47560448

Family Applications (1)

Application Number Title Priority Date Filing Date
IES20120556A IES86183B2 (en) 2011-12-23 2012-12-20 Compositions comprising cetilistat

Country Status (8)

Country Link
AU (1) AU2012101841A4 (es)
DK (1) DK201200198Y4 (es)
ES (1) ES2417408B1 (es)
FI (1) FI10194U1 (es)
FR (1) FR2984745B3 (es)
IE (1) IES86183B2 (es)
IT (1) ITTO20121118A1 (es)
NL (1) NL2009995C2 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
AR022204A1 (es) * 1999-01-08 2002-09-04 Norgine Bv Compuesto, proceso para su preparacion, composicion farmaceutica y producto comestible que lo comprende.
US20090208584A1 (en) * 2005-06-09 2009-08-20 Tomohiro Yoshinari Solid preparation
JP2010254623A (ja) * 2009-04-24 2010-11-11 Takeda Chem Ind Ltd ベンゾオキサジノン化合物の結晶

Also Published As

Publication number Publication date
ES2417408R1 (es) 2013-10-15
ES2417408A2 (es) 2013-08-07
NL2009995A (en) 2013-06-26
FR2984745B3 (fr) 2017-12-22
AU2012101841A4 (en) 2013-01-17
IES86183B2 (en) 2013-05-08
FR2984745A3 (fr) 2013-06-28
ITTO20121118A1 (it) 2013-06-24
DK201200198U1 (en) 2013-04-12
FI10194U1 (fi) 2013-08-20
DK201200198Y4 (da) 2018-09-17
NL2009995C2 (en) 2013-09-18
ES2417408B1 (es) 2014-11-26

Similar Documents

Publication Publication Date Title
US20070087048A1 (en) Oral dosage combination pharmaceutical packaging
RU2500398C2 (ru) Композиция, включающая фенофибриновую кислоту или ее физиологически приемлемую соль, и капсула, включающая композицию
US7259186B2 (en) Salts of fenofibric acid and pharmaceutical formulations thereof
EP1933815A2 (en) Pharmaceutical packaging of an oral dosage combination
US20070134324A1 (en) Therapeutic combinations
US20130018101A1 (en) Salts of fenofibric acid and pharmaceutical formulations thereof
TW201304780A (zh) 於納曲酮療法中增加藥物生物可利用性
US9060979B2 (en) Antidepressant
AU2012101841A4 (en) Compositions comprising cetilistat
DE202012104963U1 (de) Cetilistat aufweisende Zusammensetzungen
WO2020210878A1 (en) Compositions and methods for treating, ameliorating and preventing h. pylori infections
WO2013092786A1 (en) Compositions comprising cetilistat
IES86183Y1 (en) Compositions comprising cetilistat
IE20120556U1 (en) Compositions comprising cetilistat
EP1832285A1 (en) Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
AT13775U1 (de) Pharmazeutische Zusammensetzung
JPH0640936A (ja) 高脂血症の予防及び治療剤
JP2022092014A (ja) 医薬品
CN1174035A (zh) 一种可控制类风湿病炎症和骨变的抗风湿胶囊

Legal Events

Date Code Title Description
HH66 Infringement - evidence submitted under section 66(3)
MM4A Patent lapsed